CD8A and neoplasm: These include enhancing the infiltration of CD8+ T cells, promoting Tumor-associated macrophages (TAMs) recruitment, and reducing the levels of transforming growth factor-β (TGF-β) as well as decreasing PD-L1 expression [49].